Fischer, A <br/><br/>
Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.  [electronic resource] 

 -  The New England journal of medicine  May 1991 
 - 1451-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0028-4793 
<br/><br/><label>Standard No.: </label>10.1056/NEJM199105233242102  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Monoclonal--administration & dosage<br/>Antigens, CD<br/>Antigens, Differentiation--analysis<br/>Antigens, Differentiation, B-Lymphocyte--analysis<br/>B-Lymphocytes--immunology<br/>Bone Marrow Transplantation<br/>CD24 Antigen<br/>Cell Adhesion Molecules<br/>Child<br/>Child, Preschool<br/>Graft Rejection<br/>Graft vs Host Disease--complications<br/>Humans<br/>Immunosuppression Therapy--adverse effects<br/>Infant<br/>Injections, Intravenous<br/>Lectins<br/>Lymphoproliferative Disorders--etiology<br/>Membrane Glycoproteins<br/>Middle Aged<br/>Organ Transplantation<br/>Postoperative Complications--therapy<br/>Sialic Acid Binding Ig-like Lectin 2